Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
33733 Results Found
HHS, Defense Department invest in manufacturing demonstration to produce 100 million COVID-19 investigational vaccine doses
The Department of Health and Human Services announced that it will partner with the Department of Defense to fund the advanced development — including clinical trials and large-scale manufacturing — of a COVID-19 investigational vaccine from Sanofi and GlaxoSmithKline.
NASEM releases draft framework for allocating a COVID-19 vaccine, seeks public comment
The National Academies of Sciences, Engineering, and Medicine today released for public comment a discussion draft of a preliminary framework to assist policymakers in planning for equitable allocation of a vaccine against COVID-19.
AHA Comments on NASEM’s Discussion Draft of the Preliminary Framework for Equitable Allocation of COVID-19 Vaccine
AHA comments on the National Academies of Sciences, Engineering and Medicine’s Discussion Draft of the Preliminary Framework for Equitable Allocation of COVID-19 Vaccine.
HHS quickens pace of Johnson & Johnson COVID-19 vaccine candidate
The Department of Health and Human Services said it will speed the development and manufacturing of vaccines to prevent COVID-19, starting a candidate from Johnson & Johnson subsidiary Janssen Research & Development.
Agencies partner with private sector to speed COVID-19 vaccine, treatments
The Department of Health and Human Services will partner with more than a dozen biopharmaceutical companies and the European Medicines Agency to prioritize vaccine and drug candidates, streamline clinical trials and coordinate regulatory processes to respond to the pandemic, the National Institutes of Health announced.
FDA issues vaccine development guidance, authorizes new molecular-based COVID-19 test
The Food and Drug Administration issued guidance for the development of a SARS-CoV-2 vaccine, outlining key considerations to satisfy requirements for chemistry, manufacturing and control, nonclinical and clinical data.
HHS backs AstraZeneca COVID-19 vaccine candidate, could be ready by October
A collaboration between the Department of Health and Human Services and AstraZeneca is projected to make available 300 million doses of a COVID-19 vaccine, the first of which could be available as early as October, HHS said.
Pair of COVID-19 vaccine candidates move on to next trial phases
A COVID-19 trial vaccine developed by the University of Oxford and AstraZeneca produced neutralizing antibody responses in patients with SARS-CoV-2, according to a study published July 20 in The Lancet.
National Academies to convene July 24 meeting on COVID-19 vaccine’s equitable allocation
The National Academies of Sciences, Engineering, and Medicine and the National Academy of Medicine July 24 will host its inaugural committee meeting on the equitable allocation of a COVID-19 vaccine.
Moderna to produce 100M doses of its vaccine candidate for U.S.
The departments of Health and Human Services and Defense will pay Moderna Inc. about $1.5 billion to produce and deliver 100 million doses of its COVID-19 vaccine candidate to vaccinate Americans if authorized by the Food and Drug Administration, the agencies announced.